Pharmanex Supplement Definition Could Lead To Health Risk, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
FDA adoption of Pharmanex' definition of a dietary supplement would expose the public to "active drug ingredients whose safety and effectiveness has not been demonstrated," the agency argues in an Aug. 27 memorandum filed in the Cholestin case in Salt Lake City, Utah federal court.